Heather A. Berger, Director at Entasis Therapeutics Holdings, holds 1.30K shares in Design Therapeutics (Ticker: DSGN), holds 0.00 shares in Entasis Therapeutics Holdings (Ticker: ETTX). Most recently, Heather A. Berger Bought ― shares of Design Therapeutics on Mar 25, 2024 for an estimated value of 4.86K.